Skip to content

Insider · CIK 0001227758

Robert P Restrepo Jr

director

Files at RLI (RLI CORP), GNW (GENWORTH FINANCIAL INC), ACT (Enact Holdings, Inc.). First filing Jun 6, 2025, latest May 26, 2026.

Robert P Restrepo Jr files SEC Form 4 as director at ACT (Enact Holdings, Inc.), and also at GNW (GENWORTH FINANCIAL INC), RLI (RLI CORP). Since Jun 6, 2025, Robert P Restrepo Jr has reported 0 open-market buys worth $0 and 4 open-market sells worth $1.4M, the latest filed on May 26, 2026.

A track record needs three past buys with six months of prices behind them; Robert P Restrepo Jr has 0, so none is measured yet.

The newest scored trade: sold $456k of GNW on May 22, 2026, filed May 26, 2026, scored 50 (moderate). In the last 12 months: 0 buys worth $0 and 3 sells worth $1.0M.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $1.4M sold

Where the trades landed

Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.

ACT: Enact Holdings, Inc.

ACTOct 9, 2026 · close 45.97

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

GNW: GENWORTH FINANCIAL INC

GNWOct 9, 2026 · close 9.40

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
50Moderate
GNWsell 2
GENWORTH FINANCIAL INC
$456k
50,000 shares
-35%+35% from low-3% from high
55Moderate
ACTsell 2
Enact Holdings, Inc.
$215k
5,000 shares
-100%+39% from low-1% from high
58Moderate
ACTsell 2
Enact Holdings, Inc.
$374k
10,000 shares
-67%+22% from low-5% from high
48Moderate
ACTsell 2
Enact Holdings, Inc.
$347k
10,000 shares
-40%+12% from low-7% from high

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Feb 11, 2026 ACT
Enact Holdings, Inc.
5,000
0.00% of outstanding
$215kFeb 11, 2026$374k
Nov 19, 2025 ACT
Enact Holdings, Inc.
7,438
0.01% of outstanding
$278kNov 19, 2025$96k
Nov 18, 2025 ACT
Enact Holdings, Inc.
2,562
0.00% of outstanding
$96kNov 18, 2025none
Jun 4, 2025 ACT
Enact Holdings, Inc.
10,000
0.01% of outstanding
$347kJun 4, 2025none
Mar 13, 2025 RLI
RLI CORP
2,864
0.00% of outstanding
$210kMar 13, 2025none

Transactions

Every row this insider has filed, 21 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 17, 2026ACT
Enact Holdings, Inc.
AGrant or award
Deferred Stock Unitsderivative
+177$0.00$035,02322 d ago
Jun 18, 2026ACT
Enact Holdings, Inc.
AGrant or award
Deferred Stock Unitsderivative
+201$0.00$034,846Jun 23, 2026
May 22, 2026GNW
GENWORTH FINANCIAL INC
SOpen-market sale
Common Stock
-50,000$9.12$456k92,655May 26, 2026
May 20, 2026GNW
GENWORTH FINANCIAL INC
AGrant or award
Common Stock
+18,264$9.03$165k142,655May 21, 2026
May 13, 2026ACT
Enact Holdings, Inc.
AGrant or award
Deferred Stock Unitsderivative
+3,940$0.00$034,645May 15, 2026
Mar 19, 2026ACT
Enact Holdings, Inc.
AGrant or award
Deferred Stock Unitsderivative
+162$0.00$030,705Mar 23, 2026
Feb 11, 2026ACT
Enact Holdings, Inc.
SOpen-market sale
Common Stock
-5,000$42.95$215k0Feb 13, 2026
Dec 11, 2025ACT
Enact Holdings, Inc.
AGrant or award
Deferred Stock Unitsderivative
+165$0.00$030,543Dec 15, 2025
Nov 18, 2025ACT
Enact Holdings, Inc.
SOpen-market sale
Common Stock
-2,562$37.41$96k12,438Nov 20, 2025
Nov 19, 2025ACT
Enact Holdings, Inc.
SOpen-market sale
Common Stock
-7,438$37.39$278k5,000Nov 20, 2025
Sep 8, 2025ACT
Enact Holdings, Inc.
AGrant or award
Deferred Stock Unitsderivative
+168$0.00$030,378Sep 10, 2025
Jun 4, 2025ACT
Enact Holdings, Inc.
AGrant or award
Deferred Stock Unitsderivative
+186$0.00$030,210Jun 13, 2025
Jun 4, 2025ACT
Enact Holdings, Inc.
SOpen-market sale
Common Stock
-10,000$34.72$347k15,000Jun 6, 2025
May 22, 2025GNW
GENWORTH FINANCIAL INC
AGrant or award
Common Stock
+23,681$6.97$165k124,391May 23, 2025
May 14, 2025ACT
Enact Holdings, Inc.
AGrant or award
Deferred Stock Unitsderivative
+4,753$0.00$030,024May 16, 2025
May 13, 2025RLI
RLI CORP
AGrant or award
Restricted Stock Unitderivative
+1,681$0.00$01,681May 15, 2025
May 2, 2025RLI
RLI CORP
MOption exercise
Common Stock
+1,396$0.00$024,708May 5, 2025
May 2, 2025RLI
RLI CORP
JOther
Common Stock
+44$0.00$024,752May 5, 2025
May 2, 2025RLI
RLI CORP
MOption exercise
Restricted Stock Unitderivative
-1,396$0.00$00May 5, 2025
Mar 14, 2025ACT
Enact Holdings, Inc.
AGrant or award
Deferred Stock Unitsderivative
+143$0.00$025,272Mar 18, 2025
Dec 5, 2024ACT
Enact Holdings, Inc.
AGrant or award
Deferred Stock Unitsderivative
+134$0.00$025,129Dec 9, 2024

Questions about Robert P Restrepo Jr

Answered from the filings on this page, as of the latest one.

Is Robert P Restrepo Jr buying or selling?

In the last 12 months Robert P Restrepo Jr reported 0 open-market buys worth $0 and 3 open-market sells worth $1.0M on SEC Form 4; the latest was sold $456k of GNW on May 22, 2026. Grants, option exercises and tax withholding are not counted.

How did Robert P Restrepo Jr's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Robert P Restrepo Jr has 0.

Where does Robert P Restrepo Jr file Form 4?

Robert P Restrepo Jr has filed Form 4 at ACT (Enact Holdings, Inc.); GNW (GENWORTH FINANCIAL INC); RLI (RLI CORP). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.